ArticleKidney diseases (Basel, Switzerland)

Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials.

Zhiming Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.